Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bader

Showing results (211-220 of 303) with videos related to

Pageof 31
Sort By:
Bone Marrow Transplantation|January 6, 2004
Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseasesP Lang, T Klingebiel, P Bader, et al.
Early Human Development|June 29, 2016
Maternal CD4+ microchimerism in HIV-exposed newborns after spontaneous vaginal delivery or caesarean sectionH Buxmann, A Reitter, S Bapistella, et al.
Klinische Padiatrie|March 2, 2012
Impact of minimal residual disease detection prior to autologous stem cell transplantation for post-transplant outcome in high risk neuroblastomaK Bochennek, R Esser, T Lehrnbecher, et al.
Gastroenterologie Clinique Et Biologique|December 1, 1984
[Treatment of duodenal ulcer outbreak with omeprazole. Results of a multicenter non-controlled study]A Blanchi, A Rotenberg, J C Soulé, et al.
Bone Marrow Transplantation|March 12, 2013
Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantationE Rettinger, H Bonig, S Wehner, et al.
British Journal of Haematology|May 3, 2000
Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapseP Bader, K Stoll, S Huber, et al.
Leukemia|August 30, 2002
Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALLP Bader, J Hancock, H Kreyenberg, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2014
Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patientsF Moltzahn, J Karnes, P Gontero, et al.
Bone Marrow Transplantation|August 6, 2003
A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donorsM Eyrich, C Leiler, P Lang, et al.
Leukemia|April 10, 2009
WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantationG Weber, J Karbach, S Kuçi, et al.
Pageof 31

Showing results (211-220 of 303) with videos related to

Sort By:
Pageof 31
Bone Marrow Transplantation|January 6, 2004
Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseasesP Lang, T Klingebiel, P Bader, et al.
Early Human Development|June 29, 2016
Maternal CD4+ microchimerism in HIV-exposed newborns after spontaneous vaginal delivery or caesarean sectionH Buxmann, A Reitter, S Bapistella, et al.
Klinische Padiatrie|March 2, 2012
Impact of minimal residual disease detection prior to autologous stem cell transplantation for post-transplant outcome in high risk neuroblastomaK Bochennek, R Esser, T Lehrnbecher, et al.
Gastroenterologie Clinique Et Biologique|December 1, 1984
[Treatment of duodenal ulcer outbreak with omeprazole. Results of a multicenter non-controlled study]A Blanchi, A Rotenberg, J C Soulé, et al.
Bone Marrow Transplantation|March 12, 2013
Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantationE Rettinger, H Bonig, S Wehner, et al.
British Journal of Haematology|May 3, 2000
Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapseP Bader, K Stoll, S Huber, et al.
Leukemia|August 30, 2002
Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALLP Bader, J Hancock, H Kreyenberg, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2014
Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patientsF Moltzahn, J Karnes, P Gontero, et al.
Bone Marrow Transplantation|August 6, 2003
A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donorsM Eyrich, C Leiler, P Lang, et al.
Leukemia|April 10, 2009
WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantationG Weber, J Karbach, S Kuçi, et al.
Pageof 31